Unveiling Henry Schein (HSIC) Q4 Outlook: Wall Street Estimates for Key Metrics

Core Viewpoint - Henry Schein (HSIC) is expected to report a significant increase in quarterly earnings and revenues, with earnings per share projected at $1.19, an 80.3$3.27 billion, reflecting an 8.5% year-over-year growth [1]. Earnings Estimates - The consensus EPS estimate has been revised 0.7% lower over the last 30 days, indicating a reevaluation by analysts [2]. - Revisions to earnings estimates are crucial as they serve as indicators for predicting investor actions regarding the stock [3]. Revenue Estimates - Analysts predict 'Net Sales- Healthcare Distribution- Global' to be $3.09 billion, a 10$1.96 billion, reflecting a 9% increase from the prior-year quarter [5]. - 'Net Sales- Healthcare Distribution- Medical- Global' is expected to reach $1.12 billion, indicating an 11.8$225.31 million, suggesting a 6.3% increase year-over-year [6]. Geographic Revenue Estimates - 'Geographic Revenue- International- Health Care Distribution' is expected to be $848.16 million, a 9.4$1.15 billion, reflecting a 9.5% year-over-year change [7]. - 'Geographic Revenue- North America- Medical' is estimated to reach $1.10 billion, indicating a 12.8$2.26 billion, reflecting an 11.1% year-over-year change [10]. Stock Performance - Over the past month, Henry Schein shares have recorded a return of +4.1%, outperforming the Zacks S&P 500 composite's +2.6% change [10].